Stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat: Prevention by diazepam but not ondansetron

Journal of Neurochemistry

Volumn 66, Issue 5, 1996, Pages 2041-2049

  Nevo, Igal ^a   Becker, Christel ^a   Hamon, Michel ^a   Benoliel, Jean Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Anxiolytics; Cholecystokinin like material; Frontal cortex; Microdialysis; Stress

Indexed keywords

ANXIOLYTIC AGENT; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; DIAZEPAM; ONDANSETRON; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; DRUG MECHANISM; FRONTAL CORTEX; MALE; NEUROTRANSMISSION; NONHUMAN; PANIC; PRIORITY JOURNAL; RAT; STRESS;

EID: 0029917904     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66052041.x     Document Type: Article

References (52)

1. Albus M., Zahn T. P., and Breier A. (1992) Anxiogenic properties of yohimbine. I. Behaviour, physiological and biochemical measures. Eur. Arch. Psychiatry Clin. Neurosci. 241, 337-344.
2. 3 receptor antagonist with anxiolytic-like properties in animal models. Psychopharmacology (Berlin) 117, 137-148.
3. B receptors, inhibits the release of cholecystokinin-like material from the rat spinal cord in vitro. Brain Res. 590, 255-262.
4. Bickerdike M. J., Marsden C. A., Dourish C. T., and Fletcher A. (1994) The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zeromaze. Eur. J. Pharmacol. 271, 403-411.
5. Bourgoin S., Morot-Gaudry Y., Glowinski J., and Hamon M. (1973) Stimulating effect of short term ether anaesthesia on central 5-HT synthesis and utilization in the mouse brain. Eur. J. Pharmacol. 22, 209-211.
6. Bourin M., Bradwejn J., and Nixon M. K. (1993) Provocative agents and the biology of panic attacks, in Anxiety: Neurobiology, Clinic and Therapeutic Perspectives, Vol. 232 (Hamon M., Ollat H., and Thiebot M.-H., eds), pp. 15-23. INSERM-John Libbey Eurotext Ltd., Paris.
7. Bradwejn J., Koszycki D., and Meterissian G. (1990) Cholecystokinin-tetrapeptide induced panic attacks in patients with panic disorder. Can. J. Psychiatry 35, 83-85.
8. Bradwejn J., Koszycki D., Couëtoux du Tertre A., Bourin M., Palmour R., and Ervin F. (1992) The cholecystokinin hypothesis of panic and anxiety disorders: a review. J. Psychopharmacol. 6, 345-351.
9. Bradwejn J., Koszycki D., Couëtoux du Tertre A., van Megen H., den Boer J., Westenberg H., and Annable L. (1994) The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch. Gen. Psychiatry 51, 486-493.
10. Brodin K., Ögren S. O., and Brodin E. (1994) Clomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regions. Eur. J. Pharmacol. 263, 175-180.
11. Burgunder J. M and Young W. S. III (1990) Cortical neurons expressing the cholecystokinin gene in the rat: distribution in the adult brain, ontogeny, and some of their projections. J. Comp Neurol. 300, 26-46.
12. Charney D. S., Heninger G R., and Redmond D. E. (1983) Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci. 33, 19-29.
13. Cheng C. H K., Costall B., Ge J., and Naylor R. J. (1993) The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats. Br. J. Pharmacol. 110, 1079-1084.
14. de Montigny C. (1989) Cholecystokinin-tetrapeptide induces panic-like attacks in healthy volunteers. Arch. Gen. Psychiatry 46, 511-517.
15. 3 antagonists ondansetron, zacopride, 3α-tropanyl-1H-indole-3-carboxylic acid ester and 1αH,3α,5αH-tropan-3-yl-3,5-dichlorobenzoate. Drug Dev. Res. 23, 289-300.
16. Feenstra M. G. P., Botterblom M. H. A., and Van Uum J. F. M. (1995) Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: inhibition by diazepam. Neurosci. Lett. 189, 81-84.
17. 3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology (Berlin) 99, 248-251.
18. Finlay J. M., Zigmond M. J., and Abercrombie E. D. (1995) Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 64, 619-628.
19. Gaillet S., Lachuer J., Malaval F., Assenmacher I., and Szafarczyk A. (1991) The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors. Exp. Brain Res. 87, 173-180.
20. 3 antagonist MDL-72222 exacerbates ethanol withdrawal seizures in mice. Alcohol Clin. Exp. Res. 18, 410-414.
21. Harro J., Kiivet R.-A., Lang A., and Vasar E. (1990) Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics. Behav. Brain Res. 39, 63-71.
22. Ingram S. M., Krause R. G. II, Baldino F. Jr., Skeen L. C., and Lewis M. E. (1989) Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry. J. Comp. Neurol. 287, 260-272.
23. 3 receptor antagonist. Br. J. Pharmacol. 93, 985-993.
24. Lydiard R. B. (1994) Neuropeptides and anxiety: focus on cholecystokinin. Clin. Chem 40, 315-318.
25. Maidment N. T., Brumbaugh D. R., Rudolph V. D., Erdelyi E., and Evans C. J. (1989) Microdialysis of extracellular endogenous opioid peptides from rat brain in vivo. Neuroscience 33, 549-557.
26. Maidment N. T., Siddall B. J., Rudolph V. R., Erdelyi E., and Evans C. J. (1991) Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: microdialysis combined with a sequential multiple antigen radioimmunoassay. Neuroscience 45, 81-93.
27. Matsas R., Turner A. J., and Kenny A. J. (1984) Endopeptidase 24-11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin (CCK-8). FEBS Lett. 175, 124-128.
28. 3 receptors in rat cerebral cortex and nucleus accumbens. Br. J. Pharmacol. 103, 1790-1794.
29. Paxinos P. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, Sydney.
30. Pellow S., Chopin P., File S. E., and Briley M. (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149-167.
31. Pellow S., Johnston A. L., and File S. E. (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes and interactions with yohimbine and FG7142 using the elevated plus-maze test in the rat. J. Pharm. Pharmacol. 39, 917-928.
32. Pratt J. A. and Brett R. R. (1995) The benzodiazepine receptor inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain. Neurosci. Lett. 184, 197-200.
33. 3 receptor antagonists of release of cholecystokinin-like immunoreactivity from the frontal cortex of freely moving rats. Naunyn Schmiedebergs Arch. Pharmacol. 347, 111-114.
34. Ravard S. and Dourish C. T. (1990) Cholecystokinin and anxiety. Trends Pharmacol. Sci. 11, 271-273.
35. Rex A., Marsden C. A., and Fink H. (1994) 5-HT-CCK interactions in anxiety-related behaviour studied using microdialysis, in Monitoring Molecules in Neuroscience: Proceedings of the 6th International Conference on In Vivo Methods (Louilot A., Durkin T., Spampinato U., and Cador M., eds), pp. 221-222. Seignosse, France.
36. 3 receptor antagonists in development as anxiolytics. Exp. Opin. Invest. Drugs 4, 333-342.
37. 3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice. Psychopharmacology (Berlin) 117, 306-312.
38. Rose C., Camus A., and Schwartz J. C. (1988) A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain. Proc. Natl. Acad. Sci. USA 85, 8326-8330.
39. Schiffmann S. N. and Vanderhaeghen J. J. (1991) Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system. J. Comp. Neurol. 304, 219-233
40. Seroogy K. B., Fallon J. H., Loughlin S. E., and Leslie F. M. (1985) Few cortical cholecystokinin immunoreactive neurons have long projections. Exp. Brain Res. 59, 533-542.
41. Shepherd J. K., Rodgers R. J., Blanchard R. J., Magee L. K., and Blanchard D. C. (1993) Ondansetron, gender and antipredator defensive behaviour. J. Psychopharmacol. 7, 72-81.
42. Shimizu N., Take S., Hori T., and Oomura Y. (1992) In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilization stress in rats. Brain Res. Bull. 28, 727-734.
43. Sternberg E. M., Glowa J. R., Smith M. A., Calogero A. E., Listwak S. J., Aksentijevich S., Chrousos G. P., Wilder R. L., and Gold P. W. (1992) Corticotropin releasing hormone-related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res. 570, 54-60.
44. Thiébot M.-H. (1986) Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines? Pharmacol Biochem. Behav. 24, 1471-1477.
45. Vallebuona F., Paudice P., and Raiteri M. (1993) Release of cholecystokinin-like immunoreactivity in the frontal cortex of conscious rats as assessed by transcerebral microdialysis: effects of different depolarizing stimuli. J. Neurochem. 61, 490-495.
46. Vasar E., Peuranen E., Harro J., Lang A., Oreland L., and Männistö P. T (1993) Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein. Naunyn Schmiedebergs Arch. Pharmacol. 348, 96-101.
47. Wong Y. N., Chien B. M., and D'mello A. P. (1994) Analysis of corticosterone in rat plasma by high-performance liquid chromatography. J. Chromatogr. 661, 211-218.
48. Wright I. K., Heaton M., Upton N., and Marsden C. A. (1992a) Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Psychopharmacology (Berlin) 107, 405-414.
49. Wright I. K., Upton N., and Marsden C. A. (1992b) Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berlin) 109, 338-346.
50. You Z.-B., Herrera-Marschitz M., Brodin E., Meana J. J., Morino P., Hökfelt T., Silveira R., Goiny M., and Ungerstedt U. (1994) On the origin of striatal cholecystokinin release: studies with in vivo microdialysis. J. Neurochem. 62, 76-85.
51. Young R. and Johnson D. N. (1991) A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol. Biochem. Behav. 40, 739-743.
52. Zouaoui D., Benoliel J.-J., Conrath M., and Cesselin F. (1990) Cholecystokinin-like immunoreactivity in the dorsal horn of the rat spinal cord: an attempt to analyse contradictory results between immunocytochemistry and radioimmunoassay. Neuropeptides 17, 177-185.